Listen Top Shows Blog

12: Dealcast: Allergan reaction

12: Dealcast: Allergan reaction

Update: 2019-08-09

Share

Description

The European Commission (EC) is reviewing AbbVie’s [NYSE:ABBV] proposed acquisition of Botox producer Allergan [NYSE:AGN]. The merging parties have already pledged to divest such products as brazikumab, a drug under development for ulcerative colitis and Crohn’s disease, and Zenpep (pancrelipase), which treats a pancreatic disorder, but the EC may want more changes if it is to approve the deal. Dealreporter’s Pablo Mayo Cerqueiro and Mergermarket’s Mintoi Chessa-Florea joined us to discuss how the EC’s review is likely to go.

Comments

In Channel

The European SPACs boom and SS&C Intralinks Deal Flow Predictor

The European SPACs boom and SS&C Intralinks Deal Flow Predictor

2021-03-3020:27

Conference coverage: Tulane Law School's virtual conference

Conference coverage: Tulane Law School's virtual conference

2021-03-3016:51

Dissent involving Cayman incorporated Chinese companies taken private from US exchanges

Dissent involving Cayman incorporated Chinese companies taken private from US exchanges

2021-03-1614:03

Where ESG fits into shareholder activism

Where ESG fits into shareholder activism

2021-03-1510:44

Key Chinese regulatory approval for Cisco's acquisition of Acacia

Key Chinese regulatory approval for Cisco's acquisition of Acacia

2021-03-0318:32

US antitrust and merger control outlook under President Biden

US antitrust and merger control outlook under President Biden

2021-03-0311:39

M&A Outlook 2021

M&A Outlook 2021

2021-01-2216:05

Top tech M&A trends for 2021

Top tech M&A trends for 2021

2021-01-1315:13

2: Dealcast: Activism trends in 2020

2: Dealcast: Activism trends in 2020

2020-03-0219:25

1: Tipping Point - Shareholder Activism: Shift to bigger, healthier targets

1: Tipping Point - Shareholder Activism: Shift to bigger, healthier targets

2020-02-1119:09

8: Tipping Point: Deal Terms

8: Tipping Point: Deal Terms

2020-10-1327:19

7: Dealcast: Covid-19 and healthcare M&A

7: Dealcast: Covid-19 and healthcare M&A

2020-04-2918:26

6: Tipping Point: Learning Good Habits in Bad Times

6: Tipping Point: Learning Good Habits in Bad Times

2020-04-2426:36

5: Tipping Point: COVID-19’s impact on M&A

5: Tipping Point: COVID-19’s impact on M&A

2020-03-2527:38

3: Dealcast: LatAm M&A Policy Wrap

3: Dealcast: LatAm M&A Policy Wrap

2020-03-0925:43

13: Dealcast: Vertical farming grows up

13: Dealcast: Vertical farming grows up

2019-11-1309:51

12: Dealcast: Allergan reaction

12: Dealcast: Allergan reaction

2019-08-0913:07

11: Dealcast: KKR’s play for Axel Springer

11: Dealcast: KKR’s play for Axel Springer

2019-06-2010:02

10: Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM

10: Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM

2019-06-1415:41

9: Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling

9: Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling

2019-05-3118:14

00:00

00:00

x

12: Dealcast: Allergan reaction

12: Dealcast: Allergan reaction